Login / Signup

Borderline Resectable Pancreatic Cancer: Challenges for Clinical Management.

Ali FawazOmar Abdel-Rahman
Published in: Cancer management and research (2022)
Though progress has been made, the optimal management of BR-PDAC is uncertain. Phase III trials utilizing modern chemotherapeutic regimens are needed to establish a standard of care.
Keyphrases